Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1995
08/22/1995US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site
08/22/1995US5444151 Platelet derived growth factor antagonists
08/22/1995US5444149 Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation
08/22/1995US5444049 Peptide compounds derived from boronic acid
08/22/1995US5444046 Polypeptides
08/22/1995US5444045 Method of administering IGF-1, IGF-2, and analogs thereof to birds
08/22/1995US5444044 Synthetic polypeptides as inhibitors of HIV-1
08/22/1995US5443969 In vivo system for expression and packaging a genetic engineered single stranded RNA of unlimited length into pseudovirus particles comprised of plant viral coat proteins; storage stability, ribonuclease resistant
08/22/1995US5443967 DNA encoding the cancer associated SCM recognition factor
08/22/1995US5443966 Expression of tetanus toxin fragment C
08/22/1995US5443965 Peptide antigens used in diagnosis
08/22/1995US5443957 Cancer diagnosis
08/22/1995US5443956 Detection, quantitation and classification of RAS proteins in body fluids and tissues
08/22/1995US5443955 Receptor membranes and ionophore gating
08/22/1995US5443952 Reacting a serum sample with sulfatide and determining the titer of antisulfatide igg and igm antibody that binds to sulfatide to diagnose neuropathy
08/22/1995US5443855 For skin, hair, eyes and nails; analog for animal collagen
08/22/1995US5443831 A polynucleotide immunogens protecting chicken against viral disease
08/22/1995US5443828 AIDS vaccine
08/22/1995US5443827 Chimeric molecule; anticoagulants
08/22/1995US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis
08/22/1995US5443816 Peptide-metal ion pharmaceutical preparation and method
08/22/1995US5443815 Technetium-99m labeled peptides for imaging
08/22/1995US5443531 Delivery system for biologically active growth or morphogenetic factors and to a method for preparing such a delivery system
08/17/1995WO1995021943A1 Dna encoding atp-sensitive potassium channel proteins and uses thereof
08/17/1995WO1995021941A1 Methods of diagnosing ulcerative colitis and crohn's disease
08/17/1995WO1995021940A1 Assays for the identification of compounds which inhibit activation of camp and mitogen responsive genes
08/17/1995WO1995021938A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c
08/17/1995WO1995021931A1 Nucleic acid-containing composition, its preparation and use
08/17/1995WO1995021930A2 Method for preparing orphan receptor ligands
08/17/1995WO1995021929A1 Antifungal proteins, dna coding therefor, and hosts incorporating same
08/17/1995WO1995021928A1 Process for the production of a heterologous protein from a methylotrophic yeast
08/17/1995WO1995021925A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay
08/17/1995WO1995021922A2 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
08/17/1995WO1995021921A1 Mammalian thymokine genes
08/17/1995WO1995021920A1 Hematopoietic protein and materials and methods for making it
08/17/1995WO1995021919A2 Protein having tpo activity
08/17/1995WO1995021918A1 Rat osteosarcoma cell lines
08/17/1995WO1995021917A1 Mammalian cell cycle protein
08/17/1995WO1995021916A2 pp32: A NEWLY IDENTIFIED CD45-ASSOCIATED PROTEIN
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021913A1 Alteration of plant self-compatibility using genetic manipulation of the s-genes
08/17/1995WO1995021912A1 Non-pathogenic strains of hiv-1
08/17/1995WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995WO1995021867A1 Granulocyte colony-stimulating factor receptor (g-csf-r) interactive molecules
08/17/1995WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995WO1995021865A1 Immunointeractive molecules-i
08/17/1995WO1995021863A1 Prostaglandin i2 receptor
08/17/1995WO1995021862A1 Isolated antigenic oncogene peptide fragments and uses
08/17/1995WO1995021861A1 Fk-506 cytosolic binding protein
08/17/1995WO1995021860A1 Methods for variation of chromatin condensation
08/17/1995WO1995021859A1 Cytotoxic factor associated with disseminated sclerosis, its detection and quantification
08/17/1995WO1995021858A2 Mosaic polypeptide and methods for detecting the hepatitis e virus
08/17/1995WO1995021630A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995WO1995021628A1 Treatment of antibiotic associated diarrhea
08/17/1995WO1995021626A1 Methods for stimulating erythropoiesis using thrombopoietin
08/17/1995WO1995021625A1 Prolactin as a vaccine adjuvant
08/17/1995WO1995021623A1 Peptides and methods against diabetes
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
08/17/1995WO1995021528A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
08/17/1995WO1995021527A1 Stem cell engraftment
08/17/1995WO1995016040A3 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
08/17/1995WO1995007994A3 Recombinant alphavirus vectors
08/17/1995DE4420782C1 New DNA encoding a 2-oxoglutarate-malate translocator
08/17/1995DE4407837C1 Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie A method for obtaining highly pure, virus-inactivated alpha¶1¶-antitrypsin by anion-exchange chromatography
08/17/1995CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995CA2183362A1 Mosaic polypeptide and methods for detecting the hepatitis e virus
08/17/1995CA2183266A1 Hematopoietic protein and materials and methods for making it
08/17/1995CA2183260A1 Prolactin as a vaccine adjuvant
08/17/1995CA2183254A1 Mammalian cell cycle protein
08/17/1995CA2183166A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay
08/17/1995CA2183154A1 Non-pathogenic strains of hiv-1
08/17/1995CA2183147A1 Methods of diagnosing ulcerative colitis and crohn's disease
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995CA2183063A1 Prostaglandin i2 receptor
08/17/1995CA2182978A1 Peptides and methods against diabetes
08/17/1995CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995CA2182778A1 Antifungal proteins, dna coding therefor, and hosts incorporating same
08/17/1995CA2182682A1 Immunointeractive molecules-i
08/17/1995CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995CA2182574A1 Mammalian thymokine genes
08/17/1995CA2182493A1 Granulocyte colony-stimulating factor receptor (g-csf-r) interactive molecules
08/17/1995CA2182310A1 Pp32: a newly identified cd45-associated protein
08/17/1995CA2182118A1 Nucleic acid-containing composition, its preparation and use
08/17/1995CA2181803A1 Fk-506 cytosolic binding protein
08/17/1995CA2169190A1 Method for preparing orphan receptor ligands
08/17/1995CA2166313A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
08/17/1995CA2160591A1 Protein having tpo activity
08/16/1995EP0667355A1 Hirudin derivatives and process for their preparation
08/16/1995EP0667354A1 Multiple sclerosis associated cytotoxic factor, its detection and quantification
08/16/1995EP0667352A1 Process for the removal of prions in collagens and collagens thus obtained
08/16/1995EP0667344A1 3-acylamino-5-(polysubstituted phenyl)-1,4-benzodiazepin-2-ones useful as CCK-receptor agonists
08/16/1995EP0666929A1 Method of inhibiting replication of hyperproliferative cells
08/16/1995EP0666926A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods
08/16/1995EP0666922A1 Plants with reduced susceptibility to plant-parasitic nematodes
08/16/1995EP0666921A1 Monocot having dicot wound inducible promoter
08/16/1995EP0666920A1 Thrombin activatable plasminogen derivatives
08/16/1995EP0666917A1 M. paratuberculosis promoter and use thereof in immunogenic sequence expression
08/16/1995EP0666916A1 Plasmodium falciparum antigens inducing protective antibodies
08/16/1995EP0666915A1 The pct-65 serotonin receptor
1 ... 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 ... 2916